ORIGINAL RESEARCH
Accepted on 13 Nov 2025
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
Community Series in Novel Biomarkers for Predicting Response to Cancer Immunotherapy: Volume III
12k
Total downloads
63k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Accepted on 03 Nov 2025
Prognostic differential subpopulation classification and immunotherapy response prediction in pancreatic cancer patients based on the gene features of necrotizing apoptosis
ORIGINAL RESEARCH
Published on 15 Oct 2025
Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma
doi 10.3389/fimmu.2025.1663943
- 1,340 views
ORIGINAL RESEARCH
Published on 30 Sep 2025
Breaking the heterogeneity barrier: a robust prognostic signature for survival stratification and immune profiling in triple-negative breast cancer
doi 10.3389/fimmu.2025.1611917
- 1,628 views
ORIGINAL RESEARCH
Published on 24 Sep 2025
Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer
doi 10.3389/fimmu.2025.1657972
- 1,370 views
ORIGINAL RESEARCH
Published on 18 Sep 2025
TGM2 regulated by transcription factor NR3C1 drives p38 MAPK-mediated tumor progression and immune evasion in lung squamous cell carcinoma
doi 10.3389/fimmu.2025.1595907
- 1,431 views
CASE REPORT
Published on 14 Aug 2025
Lysine methyltransferase 2D deficiency drives complete response to pembrolizumab in PD-L1-High cholangiocarcinoma: a case report and review of literature
doi 10.3389/fimmu.2025.1616361
- 1,703 views
ORIGINAL RESEARCH
Published on 30 Jul 2025
Comprehensive analysis of regulatory B Cell related genes in prognosis and therapeutic response in lung adenocarcinoma
doi 10.3389/fimmu.2025.1595408
- 2,404 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jul 2025
CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis
doi 10.3389/fimmu.2025.1589423
- 1,790 views
ORIGINAL RESEARCH
Published on 30 May 2025
GPR65 is a novel immune biomarker and regulates the immune microenvironment in lung adenocarcinoma
doi 10.3389/fimmu.2025.1572757
- 3,116 views
ORIGINAL RESEARCH
Published on 30 May 2025
Serum IL-6 predicts immunotherapy-related adverse and outcome in advanced gastric and esophageal cancer patients with Anti-PD-1 treatment
doi 10.3389/fimmu.2025.1553882
- 2,214 views
- 3 citations
SYSTEMATIC REVIEW
Published on 26 May 2025
Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1592761
- 1,884 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: